Elutia Inc (ELUT)
2.80
-0.05
(-1.75%)
USD |
NASDAQ |
May 02, 16:00
2.93
+0.13
(+4.64%)
Pre-Market: 20:00
Elutia Cash from Financing (TTM): 9.84M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 9.84M |
September 30, 2023 | 24.80M |
June 30, 2023 | 11.62M |
March 31, 2023 | 9.552M |
December 31, 2022 | 8.535M |
September 30, 2022 | 8.482M |
June 30, 2022 | 8.713M |
Date | Value |
---|---|
March 31, 2022 | 9.568M |
December 31, 2021 | 6.711M |
September 30, 2021 | 35.87M |
June 30, 2021 | 40.68M |
March 31, 2021 | 46.35M |
December 31, 2020 | 51.21M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
6.711M
Minimum
Dec 2021
51.21M
Maximum
Dec 2020
20.92M
Average
9.84M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |